| Title | Neurology: Neuroimmunology and NeuroInflammation |
| Abbreviation | Neurol.: Neuroimmunol. NeuroInflammation |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Neurology (Q1); Neurology (clinical) (Q1) |
| h-index | 64 |
| Overall Rank/Ranking | 1051 |
| SCImago Journal Rank (SJR) | 2.288 |
| Impact Score | 6.82 |
| Publisher | Lippincott Williams and Wilkins Ltd. |
| Country | United States |
| ISSN | 23327812 |
| Best Quartile | Q1 |
| Coverage History | 2014-2022 |
Neurology: Neuroimmunology and NeuroInflammation is a journal covering the technologies/fields/categories related to Neurology (Q1); Neurology (clinical) (Q1). It is published by Lippincott Williams and Wilkins Ltd.. The overall rank of Neurology: Neuroimmunology and NeuroInflammation is 1051. According to SCImago Journal Rank (SJR), this journal is ranked 2.288. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 64. The best quartile for this journal is Q1.
The ISSN of Neurology: Neuroimmunology and NeuroInflammation journal is 23327812. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Neurology: Neuroimmunology and NeuroInflammation is cited by a total of 3106 articles during the last 3 years (Preceding 2022).
The Impact IF 2022 of Neurology: Neuroimmunology and NeuroInflammation is 6.82, which is computed in 2023 as per its definition. Neurology: Neuroimmunology and NeuroInflammation IF is decreased by a factor of 0.5 and approximate percentage change is -6.83% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2022 of Neurology: Neuroimmunology and NeuroInflammation is 6.82. If the same downward trend persists, Impact IF may fall in 2023 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 6.82 |
| 2021 | 7.32 |
| 2020 | 4.29 |
| 2019 | 4.47 |
| 2018 | 4.52 |
| 2017 | 4.74 |
| 2016 | 3.92 |
| 2015 | 2.04 |
| 2014 | 0.00 |
Neurology: Neuroimmunology and NeuroInflammation has an h-index of 64. It means 64 articles of this journal have more than 64 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Neurology: Neuroimmunology and NeuroInflammation is 23327812. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Neurology: Neuroimmunology and NeuroInflammation is 1051. According to SCImago Journal Rank (SJR), this journal is ranked 2.288. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 2.288 |
| 2021 | 2.453 |
| 2020 | 1.451 |
| 2019 | 1.674 |
| 2018 | 2.102 |
| 2017 | 1.959 |
| 2016 | 2.374 |
| 2015 | 0.839 |
| 2014 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 1051 |
| 2021 | 868 |
| 2020 | 2395 |
| 2019 | 1829 |
| 2018 | 1256 |
| 2017 | 1439 |
| 2016 | 1022 |
| 2015 | 5566 |
| 2014 | 32571 |
Neurology: Neuroimmunology and NeuroInflammation is published by Lippincott Williams and Wilkins Ltd.. It's publishing house is located in United States. Coverage history of this journal is as following: 2014-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Neurology: Neuroimmunology and NeuroInflammation is Neurol.: Neuroimmunol. NeuroInflammation. This abbreviation ('Neurol.: Neuroimmunol. NeuroInflammation') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Neurology (Q1); Neurology (clinical) (Q1), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Neurology: Neuroimmunology and NeuroInflammation latest impact IF is 6.82. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 7.32 (2021) and 0.00 (2014), respectively, in the last 9 years. Moreover, its average IS is 4.24 in the previous 9 years.
The Neurology: Neuroimmunology and NeuroInflammation has an SJR (SCImago Journal Rank) of 2.288, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 2.453 in 2021 and the lowest being in 2014. Furthermore, the average SJR of the Neurology: Neuroimmunology and NeuroInflammation over the previous 9-year period stands at 4.24.
The latest h-index of the Neurology: Neuroimmunology and NeuroInflammation is 64.
The Neurology: Neuroimmunology and NeuroInflammation is published by the Lippincott Williams and Wilkins Ltd., with its country of publication being the United States.
The Neurology: Neuroimmunology and NeuroInflammation is currently ranked 1051 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 868 in 2021 and its lowest position of 32571 in 2014.
The standard ISO4 abbreviation for the Neurology: Neuroimmunology and NeuroInflammation is Neurol.: Neuroimmunol. NeuroInflammation.
Neurology: Neuroimmunology and NeuroInflammation is classified as a journal that the Lippincott Williams and Wilkins Ltd. publishes.
The Neurology: Neuroimmunology and NeuroInflammation encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Neurology: Neuroimmunology and NeuroInflammation is assigned the following International Standard Serial Numbers (ISSN): 23327812.
The best quartile for the Neurology: Neuroimmunology and NeuroInflammation is Q1 (2022).
The Neurology: Neuroimmunology and NeuroInflammation coverage history can be summarized as follows: 2014-2022.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Journal of Academic Ethics | journal | 8920 | Springer Netherlands | 26 | 2.28 |
| Journal of Geriatric Physical Therapy | journal | 5578 | Lippincott Williams and Wilkins Ltd. | 43 | 1.80 |
| Business Strategy Review | journal | 31512 | Wiley-Blackwell Publishing Ltd | 33 | 0.04 |
| International Journal of Parallel, Emergent and Distributed Systems | journal | 15843 | Taylor and Francis Ltd. | 23 | 1.28 |
| Journal, Indian Academy of Clinical Medicine | journal | 24608 | Indian Academy of Clinical Medicine | 16 | 0.06 |
| Syntax | journal | 3422 | Wiley-Blackwell Publishing Ltd | 29 | 0.93 |
| Rinsan Shikenj Oha/Journal of the Hokkaido Forest Products Research Institute | journal | 25369 | Hoikkaido Forest Products Research Institute | 4 | 0.00 |
| Indian Phytopathology | journal | 14222 | Springer Nature | 11 | 1.33 |
| Rudarsko Geolosko Naftni Zbornik | journal | 14294 | University of Zagreb, Faculty of Mining, Geology and Petroleum Engineering | 17 | 1.48 |
| Expert Review of Clinical Pharmacology | journal | 5241 | Taylor and Francis Ltd. | 53 | 4.10 |
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 6.82 |
| 2021 | 7.32 |
| 2020 | 4.29 |
| 2019 | 4.47 |
| 2018 | 4.52 |
| 2017 | 4.74 |
| 2016 | 3.92 |
| 2015 | 2.04 |
| 2014 | 0.00 |
